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Abstract 
 
Methyltransferases (MTases) from the TrmI family catalyse the S-adenosyl-L-methionine 
(AdoMet)-dependent N1-methylation of tRNA adenosine 58. The crystal structure of Thermus 
thermophilus m1A58 tRNA MTase (thTrmI) in complex with S-adenosyl-L-homocysteine was 
determined at 1.7 Å resolution. This structure is closely related to that of Mycobacterium 
tuberculosis TrmI (mycoTrmI), and their comparison enabled us to enlighten two grooves in 
the TrmI structure that are large enough and electrostatically compatible to accommodate one 
tRNA per face of TrmI tetramer. We have then conducted a biophysical study based on 
electrospray ionization mass spectrometry, site-directed mutagenesis and molecular docking. 
First, we confirmed the tetrameric oligomerisation state of TrmI and we showed that this 
protein remains tetrameric upon tRNA binding with formation of complexes involving one to 
two molecules of tRNA per TrmI tetramer. Secondly, three key residues for the methylation 
reaction were identified, the universally conserved D170, and two conserved aromatic 
residues Y78 and Y194. We then used molecular docking to position a N9-methyladenine in 
the active site of TrmI. The N9-methyladenine snugly fits in the catalytic cleft where the side 
chain of D170 acts as a bidentate ligand binding the amino moiety of AdoMet and the 
exocyclic amino group of the adenosine. Y194 interacts with the N9-methyladenine ring 
whereas Y78 can stabilize the sugar ring. From our results, we propose that the conserved 
residues that form the catalytic cavity (D170, Y78 and Y194) are essential to fashion an 
optimized shape of the catalytic pocket.  
 
 
 
Keywords: TrmI, m1A58 methyltransferase, X-ray structure, noncovalent mass 
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Introduction 
 
Functional tRNAs carry a number of chemically modified nucleosides that are formed 
enzymatically after transcription, during the tRNA maturation process. To date, more than 90 
different modifications have been identified in tRNAs from various organisms.1 Among these 
post-transcriptional nucleoside modifications, N1-methyladenosine (m1A) is found at a highly 
conserved A58 position in the TΨC loop of many tRNAs in the three domains of life 
(Bacteria, Archaea and Eukarya). This modification occurs infrequently in bacteria and, for 
instance, is absent in E. coli tRNAs. On the contrary, it is common in the tRNAs of most 
eukaryotes and archaea, and this modification seems to be essential for some organisms. 
Actually, in the yeast Saccharomyces cerevisiae, mutants defective in N1-methylation of A58 
are non-viable.2 Likewise, in Thermus thermophilus, gene disruption studies have shown that 
m1A58 modification is required for growth of this bacterium at high temperatures.3 
S-Adenosyl-L-methionine (AdoMet) dependent methyltransferases (MTases) are involved 
in a wide variety of biological processes involving methylation of nucleic acids, proteins, 
phospholipids and small molecules using the ubiquitous methyl donor AdoMet. Recently, 
two essential genes of S. cerevisiae, GCD10 and GCD14 (renamed TRM6 and TRM61), were 
identified to encode the two types of subunits of the yeast m1A58 MTase.4 The recombinant 
enzyme behaves as an α2β2 heterotetramer, Trm61p being responsible for AdoMet binding 
and presumably catalysis of the methyl transfer reaction,2 whereas both types of subunits are 
essential for tRNA-binding.5 Indeed, the purified recombinant Trm61p subunit, which binds 
AdoMet, cannot bind tRNA in vitro in the absence of Trm6p.2 Interestingly, Trm61p was 
found to be closely related to a group of prokaryotic proteins which share not only the same 
AdoMet-binding site but also other highly conserved motifs. Therefore, the corresponding 
prokaryotic proteins were presumed to act as m1A58 MTases.6 This hypothesis was 
demonstrated experimentally for the bacterial orthologs in Thermus thermophilus and 
Mycobacterium tuberculosis and for the archaeal ortholog in Pyrococcus abyssi.3,7-9 These 
proteins are α4 homotetramers of Trm61p-like proteins, hereafter called TrmI. Interestingly, 
orthologs of the Trm6p protein could only be found in eukaryotes. It was shown that Trm6p, 
despite the absence of the characteristic MTases motifs, is structurally and evolutionary 
related to Trm61p suggesting that the eukaryotic m1A58 MTases evolved by gene duplication 
and speciation to form a heteromultimeric protein, whereas their prokaryotic orthologs 
remained homomultimers.6 
Despite the low level of sequence similarity between the various families of AdoMet-
MTases, most of them contain a structurally highly conserved catalytic AdoMet-binding 
domain organized in a Rossman-like fold (For a review see 10). Only one crystal structure of 
an m1A58 tRNA MTase has been reported to date, that of the M. tuberculosis Rv2118c protein 
(mycoTrmI) in complex with S-adenosyl-L-methionine.7 It shows that the catalytic C-
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terminal domain is very similar to that of other AdoMet-dependent MTases whereas the N-
terminal domain which is mainly composed of β-sheets is not found in other MTases of 
known structure. 
In the present work, we have first solved the crystal structure of the m1A58 tRNA MTase 
from T. thermophilus (thTrmI) at 1.7 Å resolution in complex with S-Adenosyl-L-
homocysteine (AdoHcy), the product after methyl transfer. We then focused our attention on 
the tRNA-binding properties of thTrmI using several biophysical techniques, including 
electrospray ionization mass spectrometry (ESI-MS), site-directed mutagenesis, steady-state 
kinetic assays, fluorescence spectroscopy and molecular docking. ESI-MS has demonstrated 
its particular suitability for the investigation of noncovalent complexes.11-13 More particularly, 
so-called noncovalent ESI-MS has been extensively used to characterize supramolecular 
assemblies involving oligonucleotides in interaction with drugs and proteins (For reviews see 
14-17). As protein:RNA systems are partly driven by electrostatic-based interactions which are 
strongly enhanced in the gas phase, ESI-MS is well suited for their characterization.18,19 
Indeed, numerous studies of protein-RNA complexes have revealed a strong agreement 
between mass spectrometric gas-phase measurements and results obtained by solution phase 
techniques.20-24 In our work, we used noncovalent ESI-MS: i) to unambiguously assess the 
oligomerisation state of thTrmI ; ii) to monitor the thTrmI oligomerisation state upon tRNA 
binding and iii) to determine the stoichiometry of the thTrmI-tRNA complexes. In addition, a 
mutagenesis study was performed to identify residues potentially crucial for the methylation 
reaction. We thus showed that the universally conserved D170 residue, together with two 
conserved aromatic residues, Y78 and Y194, which line the catalytic pocket are key residues 
for the enzymatic catalysis. Actually, D170A and Y78A variants are severely altered in their 
catalytic efficiency. Finally, we have used molecular docking to position a N9-methyladenine 
in the active site of TrmI to further investigate the possible role of these residues. 
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Results and Discussion 
 
Structure determination of T. thermophilus TrmI 
Production and purification of T. thermophilus TrmI (thTrmI) have been described by 
Droogmans and coworkers.3 However, the recombinant His6-tagged protein exhibited a low 
solubility (< 0.5 mg/mL) unless high salt concentrations were added (0.2 M imidazole-HCl 
and 0.5 M KCl). This was a serious issue for crystallization assays, in which precipitating 
solutions must be added to concentrated protein. In order to improve solubility, the N-
terminal His6-tag of thTrmI was cleaved with thrombin. Indeed, after His6-tag removal, 
thTrmI became highly soluble (> 10 mg/mL), even at moderate ionic strengths (150 mM). 
This type of behaviour has already been reported for some His-tagged proteins.25 We then 
carried out crystallization assays on the complex between thTrmI, AdoHcy and E. coli 
tRNAiMet. The latter tRNA was selected because it is devoid of modification on A58 and is a 
substrate of the T. thermophilus enzyme (see paragraph on steady-state kynetic assays). 
Although the tRNA was present in all crystallization conditions, crystals only contained the 
free thTrmI protein in complex with AdoHcy. Table 1 summarizes the data collection and 
refinement statistics. The structure of T. thermophilus TrmI protein was then solved by 
molecular replacement with the structure of m1A58 tRNA MTase from M. tuberculosis TrmI 
(PDB entry code 1I9G)7 using PHASER26 (Z score = 23.7). Actually, thTrmI shares 39% 
identical and 13% similar residues with mycoTrmI. The model was then refined to 1.7 Å, to a 
final Rfree factor of 20.9% (Table 1). The last four residues at the N-terminus were too poorly 
ordered to be included, and therefore the final model consisted of 251 residues per monomer. 
The asymmetric unit contained a dimer of thTrmI. However, the symmetry-related subunits 
interact extensively leading to a tetrameric organization of thTrmI (Figure 1(b)).  
 
Overall structure of thTrmI 
The thTrmI monomer is composed of two distinct domains connected by an extended 
linker containing a short α-helix (helix 2, Figure 1(a)). The large C-terminal domain (residues 
63-255) adopts a typical class I MTase fold which consists of a central seven-stranded β sheet 
(β1 to β6 and β8 – Figure 1(a)) flanked by α helices on both sides (αA to αE – Figure 1(a)).10 
The first five strands of the β sheet (β1 to β5 on Figure 1(a)) are parallel whereas the last two 
(β6 to β8) are antiparallel. The C-terminal domain contains the AdoMet binding site and the 
catalytic pocket. The smaller N-terminal domain (residues 5-62) is largely a β structure 
composed of six β-strands (βA to βF Figure 1(a)) and one small α helix (α1). 
The thTrmI tetramer is organised as a dimer of tight dimers. Two monomers interact via 
their extended β6 strands which form a cross-subunit, antiparallel β-sheet (Figure 1(b), pale 
and dark blue). This dimer is further stabilized by ionic interactions between helices α2 and 
α3 from each subunit (Figure 1(b)). A pair of β6 strands from each dimer packs on the related 
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β6 strands of the other dimer to form a central anti-parallel β-sheet structure. The tetramer 
interaction is limited to this β-sheet region and stabilized by both ionic and hydrophobic 
interactions, mainly a salt bridge between E220 and R224, hydrophobic interactions between 
W226 and F245, and between H234 and F237 from one dimer to H242 from the other dimer. 
The salt bridge and the hydrophobic interactions between W226 and F245 have been also 
observed on the mycoTrmI structure7 and involve conserved residues.  
In the tight dimer found in the asymmetric unit, the two cofactor-binding sites are 
occupied by AdoHcy molecules in identical conformations, similar to that of AdoMet in the 
M. tuberculosis TrmI structure. The binding cleft is formed by residues belonging to 
conserved motifs, named I, II, III, IV, (Figures 1(c), 1(d) and 7(a)).27 The adenine ring of the 
AdoHcy moiety is bound by motifs II, III, and IV via water-mediated hydrogen bonds 
between the exocyclic amino group and residues E155 and E173, and between the N7 position 
of the adenine and the backbone amide of E173 (Figure 1(c)). Adenine binding is also 
reinforced by hydrophobic contacts between its aromatic ring and residues L171, V177, 
K153, L154, Y124, A126 and A100. The ribose moiety of AdoHcy is bound by motif II, 
essentially by hydrogen bonds involving the 2’ and 3’ hydroxyl groups and residues E125 
and H130. The amino-acid part of the cofactor is mainly bound by motif I. Interestingly, an 
aspartate side chain that could be involved in the methylation reaction, the carboxylate chain 
of D170 from motif IV, participates to a direct polar interaction with the ammonium group of 
AdoHcy. The GXGXGG pattern of motif I binds to the amine and the carboxylate through a 
tight network of water-mediated hydrogen bonds involving the backbone (Figure 1(c)).  
 
Comparison with mycoTrmI structure and tRNA recogition 
Globally, the overall structure of thTrmI closely resembles that of mycoTrmI. 
Superimposition of T. thermophilus and M. tuberculosis TrmI structures gives a root mean 
square deviation of 4.47 Å for Cα, the largest variation occurring in the β-strands (β6, β7, β8) 
that protrude out of the structure. When comparing the active sites more accurately, that of 
mycoTrmI is narrower by about 1 Å than that of thTrmI. Moreover, the protruding R249 in 
mycoTrmI makes like a supplementary step at the exit of the pocket that does not exist in 
thTrmI as R249 is replaced by a shorter side chain residue (V240). As a consequence, the 
accessible surface of Y78 is twice larger in thTrmI than that of Y84 in mycoTrmI. All these 
features seem to make the methyl donor less easily accessible in mycoTrmI. Overall, in both 
structures, the adenine should enter deeply in the binding cleft to have access to the methyl 
donor therefore implicating a major deformation of the phosphodiester backbone around A58. 
It is also highly interesting to compare electrostatic potentials of their molecular surfaces 
(Figure 2). These calculations uncover that both proteins have two linked grooves of positive 
electrostatic potentials indicated by large blue surfaces on Figure 2 that are large enough to 
accommodate double-helical RNA. The first groove that covers the β-sheet region forming 
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the tetrameric architecture is less positively charged in thTrmI than in mycoTrmI; whereas the 
second groove that encompasses the N-terminal domain of one TrmI subunit and that looks 
like an open hand is more positively charged in thTrmI than in mycoTrmI. Several residues 
with basic side chains are conserved among the TrmI protein family, namely K13 (R in some 
sequences), R15 (K), R72, R127, R217 and R229 (K) together with the histidines involved in 
the formation of the tetramer H234 and H242. R15 and R217 are only conserved in bacterial 
TrmI proteins. These grooves have the dimensions to accommodate the acceptor arm (groove 
1, dimensions: 25 Å large and 45 Å long) and the anticodon one (groove 2, dimensions: 25 Å 
large and roughly 30 Å long) without steric clashes, enabling us to position the adenosine 58 
near the catalytic pocket (manual docking, data not shown). The grey line in Figure 2(a) 
indicates a possible position of the helix axis of tRNA. Numerous clashes occur within the T-
arm that undoubtedly undergoes huge conformational changes that probably involves the 
entire T-arm and not only a simple flip of the adenosine 58. These changes are difficult to 
predict and, for this reason, we could not pursue this docking. In conclusion, the conservation 
of two grooves of positively charged surfaces supports the idea that TrmI binds tRNA as a 
tetramer and that two molecules of tRNA can interact simultaneously with the TrmI tetramer. 
The fact that, in eukaryotes, the enzyme has evolved from an α4 homotetramer to an α2β2 
heterotetramer is compatible with a two tRNA per TrmI tetramer stoichiometry, one tRNA 
being expected to interact with an αβ subsystem.  
 
thTrmI is a tetramer and binds up to two tRNA molecules as a tetramer.  
Close inspection of the crystal structures of thTrmI and mycoTrmI7 revealed that the 
tetramers are formed by two pairs of extensively interacting subunits stabilized by relatively 
small numbers of contacts between the two dimers. Given the architecture of TrmI, it was of 
interest to investigate the oligomerization state of thTrmI alone and upon tRNA binding, and 
to determine the binding stoichiometry of the thTrmI-tRNA complexes. Previously reported 
gel filtration experiments have indicated that both mycoTrmI and thTrmI should form 
tetramer in solution.3,9 However, in the case of thTrmI, due to an inherent limited precision of 
this technique, it is difficult to unambiguously state whether the protein is tetrameric or 
pentameric.3 In this study, we used ESI-MS, which has been proven to be a valuable 
technique for the determination of oligomerization states of noncovalent assemblies28-31 to 
first confirm the oligomerization state of thTrmI. Figure 3(a) presents the ESI mass spectrum 
obtained for thTrmI under non-denaturing conditions and carefully controlled operating 
conditions (see Materials and Methods): a single ion distribution is observed in the m/z 4000-
5000 range. With a measured molecular weight (MW) of 115450 ± 5 Da, this distribution can 
be assigned to the +23 to +30 charge states of a thTrmI tetramer (theoretical MW = 115453 
Da). Thus, ESI-MS allowed us to unambiguously assess the tetrameric nature of the protein 
in agreement with our crystallographic results.  
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The tRNA binding stoichiometry was first investigated by gel retardation assay. As shown 
on Figure 4, the free tRNA band progressively disappears upon addition of increasing 
amounts of thTrmI evidencing thus the existence of thTrmI-tRNA interactions. Moreover, the 
free tRNA band completely disappears at 1:2 thTrmI:tRNA ratio, substantiating the formation 
of complexes involving two molar equivalents of thTrmI monomer per tRNA. To further 
confirm gel retardation experiments, we also used the potentialities of noncovalent ESI-MS 
to investigate the oligomerization state of thTrmI upon tRNA binding and to determine the 
tRNA binding stoichiometry. Titration experiments, monitored by noncovalent ESI-MS, 
involving a fixed concentration of thTrmI and increasing amounts of tRNAiMet, revealed the 
presence of three ion distributions (Figure 3(b-d)). The first one in the m/z 4000-5000 region 
with a molecular mass of 115450 ± 5 Da is related to the thTrmI tetramer. For the second ion 
distribution in the m/z 5000-5900 region, the molecular mass of 140347 ± 6 Da corresponds 
to the (thTrmI)4:(tRNA)1 complex. Finally, a third ion distribution within the m/z 5900-6800 
range with a molecular mass of 165455 ± 10 Da refers to the (thTrmI)4:(tRNA)2 complex. 
Even a ten-fold molar excess of tRNA per thTrmI tetramer does not lead to the detection of 
complexes with higher tRNA binding stoichiometries. Interestingly, upon increase of the 
tRNA concentration from 1.5 to 10 molar equivalents per thTrmI tetramer, the relative 
abundances of (thTrmI)4:(tRNA)1 and (thTrmI)4:(tRNA)2 complexes statistically increase, 
which is in favour of non-cooperative tRNA binding system and further suggests the presence 
of two independent tRNA binding sites.32 The same experiments were also carried out in 
presence of AdoHcy (data not shown) and no effect either on the binding stoichiometry of the 
complex or on the binding affinity of the tRNA for thTrmI was observed.  
As ESI-MS detects species in the gas phase of the mass spectrometer, control experiments 
are always needed to ensure that mass spectra faithfully reflect the behaviour in solution.33 
Thus, since electrostatic interactions are sensitive to the ionic strength of the medium,34,35 
experiments were carried out at different ammonium bicarbonate concentrations (Figure 5). 
Decreasing the ammonium bicarbonate concentration from 200 mM to 100 mM displaces the 
equilibrium towards the formation of (thTrmI)4:(tRNA)1 and (TrmI)4:(tRNA)2 complexes 
(Figure 5(a-b)). However, the signal intensities were dramatically lower when 100 mM 
ammonium bicarbonate was used rather than 200 mM buffer, mainly because of protein 
precipitation. Therefore, no ESI-MS analysis could be performed at buffer concentrations 
lower than 100 mM. While both (thTrmI)4:(tRNA)1 and (thTrmI)4:(tRNA)2 complexes are 
favoured at low ionic strengths, the use of higher salt concentrations destabilizes these 
assemblies (Figure 5(c-d)), leading even to a complete dissociation of thTrmI:tRNA 
complexes into thTrmI tetramer at 1250 mM ammonium bicarbonate (Figure 5(d)). The fact 
that mass spectra do reflect expected changes induced by modification of the solution 
conditions is a further evidence that allows us to definitely rule out the possibility that the 
TrmI-tRNA complexes result from an artefact of the technique. Moreover, as described in 
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other publications,22,36 an additional ESI-MS control experiment was performed in strictly 
identical experimental and operating conditions with a non-substrate RNA as a negative 
control. The absence of any thTrmI-control RNA complex on ESI mass spectra even in 
presence of a five-fold molar excess of control RNA (Figure 6) indicates that the gas phase 
detection of the TrmI-tRNA complexes arises from a specific recognition in solution and not 
from any gas phase artefact.  
In conclusion, noncovalent ESI-MS results clearly support that thTrmI remains tetrameric 
upon tRNA binding and that thTrmI binds up to two molecules of tRNA.  
 
The D170A and Y78A variants of thTrmI are severely altered in their catalytic 
efficiency.  
On the basis of multiple sequence alignments of the TrmI family members (Figure 7(a)) 
and on the comparison of the crystallographic structures of TrmI from M. tuberculosis7 and T. 
thermophilus, we chose to mutate three conserved residues, D170, Y194 and Y78 in order to 
study their involvement in adenosine binding and/or in catalysis. Figure 7(b) presents the 
thTrmI residues that are conserved or semi-conserved in the catalytic pocket, except the 
conserved residues that bind to AdoMet since their role in the catalysis mechanism is known. 
Yet, the universally conserved AdoMet-binding D170 was selected as it forms the back of the 
catalytic pocket and may also bind the adenine 58 ring of the tRNA substrate (Figure 7(b)). 
Y194 and Y78 were mutated because they respectively form the left side and the floor of the 
adenosine-binding pocket in the 3D structure (Figure 7(b)) and are conserved as aromatic 
residues among m1A58 tRNA MTases, belonging respectively to motifs V and X (Figure 
7(a)). Therefore, these aromatic residues could be involved in the stabilization of the target 
adenine that needs to be flipped out of the tRNA structure to be methylated. P196 that is 
involved in making the shape of the catalytic cavity was not selected for mutation, because in 
M. tuberculosis, it is naturally replaced by an alanine. Therefore, we individually mutated 
Y78, D170 and Y194 to alanines. We expressed and purified the variant proteins as described 
in Materials and Methods section. We then determined the kinetic and RNA-binding 
parameters for wild-type and variant proteins (Table 2).  
First, we investigated whether the mutations altered tRNA binding by the enzyme. 
Interaction with tRNA induces a quenching of the intrinsic tryptophan fluorescence of the 
protein of about 40 %. We therefore used fluorimetric titrations to determine the apparent 
dissociation constant between thTrmI variants and tRNAiMet (Table 2). All mutants showed 
quite unchanged dissociation constants (Kd about 15 ± 3 nM), thereby indicating that they 
retained a native folding and similar RNA binding ability compared to the wild-type enzyme. 
We then analysed their catalytic properties by determining their kinetic parameters kcat and KM 
for both AdoMet and tRNA substrates. The overall results are summarized in Table 2. 
Interestingly, all mutants retain some catalytic activity, but are altered to various extents, 
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essentially in their catalytic turnover kcat. The D170A mutant retains some activity, but its kcat 
value is severely reduced, by a factor of about 300. D170A also shows an increased KM for 
AdoMet substrate in agreement with the crystal structure. It seems therefore to be the most 
important residue for the catalysis of the reaction. The Y78A mutant leads to a roughly 20-
fold decrease of the catalytic turn-over constant. Its binding constant for the methyl donor is 
unchanged compared to the wild-type protein. The Y194A mutant shows a smaller decrease 
of kcat, by a factor of 3 (Table 2). The KM value for AdoMet is increased suggesting that this 
residue is involved in cofactor binding. Yet, in the crystal structure, it is not involved in a 
direct interaction with AdoHcy in contrast to D170. The mutation of Y194 to an alanine 
probably slightly destabilizes the catalytic pocket or indirectly weakens AdoMet binding. In 
conclusion, D170A is the variant that is most largely altered in its catalytic efficiency 
followed by Y78A and then Y194A. And, therefore, D170, Y78 and Y194 are key residues in 
the catalytic mechanism. 
 
The substrate adenine snugly fits in the active site pocket of thTrmI.  
To investigate the positioning of the target A58 into the catalytic pocket of T. thermophilus 
and M. tuberculosis TrmI, we decided to locate a N9-methyladenine in the catalytic pocket of 
these proteins by molecular docking. We docked a N9-methyladenine and not an adenosine or 
an AMP molecule since it is impossible to predict the conformation of the sugar of this 
flipped-out nucleotide. Moreover Y78 that makes the exit of the catalytic pocket and which 
may interact with the ribose of the adenosine 58 can also flip to prevent from steric clashes 
with the A58 ribose. As the molecules of AdoHcy present in the active sites of thTrmI have 
identical conformations to the AdoMet co-factor present in mycoTrmI, we modelled an 
AdoMet molecule in the catalytic pocket of thTrmI by superimposing the AdoMet from 
mycoTrmI with AdoHcy in thTrmI. We used the program HADDOCK37 that can take into 
account mutagenesis results by introducing data as Ambiguous Interaction Restraints (AIRs) 
to drive the docking process. An AIR is defined as an ambiguous distance between all 
residues shown to be involved in the interaction. Ambiguous intermolecular distance 
restraints were applied between D170, Y194, Y78 and the AdoMet cofactor on the one hand, 
and the N9-methyladenine, on the other hand. A distance restraint between the N1 atom of N9-
methyladenine and the methyl of AdoMet was also added. The model resulting from the 
docking with thTrmI is presented in Figure 8(a) and shows that the N9-methyladenine fits 
snugly in the cavity where methylation takes place. The same result was obtained for 
mycoTrmI (data not shown). Moreover, the methyl group introduced to substitute the ribose 
is pointing above Y78 (Figure 8(b)) enabling us to add a ribose without steric hindrance. 
Therefore, Y78 is likely to strongly interact with the ribose of the adenosine 58 probably 
participating to stabilization of the flipped-out conformation. The distance between the N9-
methyladenine N1 and the AdoMet methyl group is 2.3 Å. This corresponds to a distance 
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between the N9-methyladenine N1 and the AdoMet sulphur atom of 4.1 Å. This is in keeping 
with distances observed in co-crystal structures of other endocyclic purine N-MTases 
(distances between 3.6 Å and 4.5 Å).38 The docked model of the N9-methyladenine ring 
suggests a binding mode involving essentially Van der Waals interactions with Y194, and a 
polar contact between the exocyclic amino group of the purine and the carboxylate of D170 
(Figure 8(b)). Therefore, the side chain of D170 could act as a bidentate ligand binding the 
amino terminal moiety of AdoMet and the N6 exocyclic amino group of the adenine ring 
substrate. Thus, the sulphur-methyl bond of AdoMet is almost coplanar with the N9-
methyladenine ring and is pointing to the same direction as the N1 lone-pair orbital, which 
can be of significant importance for the chemical mechanism. We thus propose that D170 
could minimize the transition state energy by positioning both the AdoMet and the target base 
in an optimal orientation for the methylation reaction. D170 could also deprotonate the N6 
group to activate the N1 lone-pair orbital in order to attack the methyl group of AdoMet and 
to generate the exocyclic imino tautomer of N1-methyladenosine as the initial product. The 
nucleophilic attack leads to the m1A basic form which has to be subsequently protonated to 
give the m1A cationic form, stable at physiological pH (pKa = 9.3).39 As the deprotonation of 
N6 of m1A is easier than the deprotonation of N6 of the non-methylated adenine ring (pKa = 
16.7),40 it seems more reasonable that the deprotonation and the nucleophilic attack occur in 
the same elementary step. The model perfectly situates D170 to serve that role, which is most 
definitely consistent with the kinetic results. 
The chemical mechanism of adenine N1 methylation of RNA had not yet been investigated 
in contrast to the N1 methylation of guanine.41 In the case of m1G RNA methyltransferase 
(TrmD),41 an aspartate residue was shown to be involved in the deprotonation step of N1 of 
guanine. The two processes are likely to be different, as under physiological conditions, the 
N1 of guanine is protonated but that of adenine is not. DNA methyltransferases have been 
extensively studied, but the m1A modification is not encountered in DNA. The methylation of 
the N6 position of adenine has been investigated in DNA (for structural studies see 42-44) and 
more recently in rRNA.45,46 Interestingly, the main catalytic residue in m6A RNA or DNA 
MTases has been clearly identified by mutagenesis studies to be the D/N/S residue of the 
conserved pattern (D/N/S)PP(Y/F/W) which belongs to MTase motif IV (for reviews on 
DNA MTases see 47,48). In known structures of m6A DNA MTases (for example M•TaqI, 
PDB code 2ADM) or m6A RNA MTases (ErmC’, PDB code 1QAN) in complex with 
cofactor (AdoMet or AdoHcy), the position of the D/N/S residue of motif IV relative to the 
cofactor is closely similar to that of D170 residue in the T. thermophilus TrmI crystal 
structure. Additionally, two other residues have been identified to be important in catalysis in 
m6A DNA methyltransferases. These residues are aromatic and stabilize the flipped-out target 
base and/or act as cation-π catalysts. The first one is the aromatic Y/F/W residue of motif IV, 
which is proposed to stabilize the cationic transition state by cation-π interaction.49,50 And the 
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second one is the aromatic residue Y/F/W of motif VIII, which stabilizes the flipped base 
outside the DNA helix.49,50 These aromatic residues are conserved in motifs IV and VIII in 
m1A tRNA MTases (Figure 7(a), symbol o), but they are not part of the catalytic pocket in the 
TrmI structure. Strikingly, two other aromatic residues, i.e. Y78 and Y194, are located in the 
active site cavity of thTrmI (Figure 7(b)) at relative positions with respect to the AdoMet 
cofactor similar to those of the aromatic residues listed above for DNA MTases. These 
residues are also conserved as aromatic residues among m1A58 tRNA MTases and belong 
respectively to motifs X and V (Figure 7(a)). The noticeable structural similarity between the 
catalytic pocket of m1A tRNA MTases and m6A DNA MTases suggests a similar role in 
catalysis for these residues. Y78 is thus the most probable candidate for the stabilization of 
the flipped-out adenosine given its position in the catalytic pocket and the dramatic decrease 
of kcat of the Y78A mutant. Then, Y194 could act as a cation-π catalyst to stabilize a cationic 
transition state. These roles are also in agreement with our docking results. 
 
Coordinates and structure factors for T. thermophilus TrmI protein in complex with AdoHcy 
have been deposited at the Protein Data Bank with accession code 2PWY. 
 13 
Materials and Methods 
 
Expression and purification of thTrmI for structural studies 
Recombinant T. thermophilus TrmI protein (255 residues) was overexpressed and purified 
as previously described.3 The N-terminal His6-tag was removed by thrombin cleavage 
(25 units of thrombin per mg of protein) performed overnight at ambient temperature. The 
thTrmI protein was then further purified by gel filtration on a HiLoad 26/60 Superdex 200 
prepgrade chromatography column (Amersham Biosciences) equilibrated in 50 mM Tris-HCl 
buffer (pH 8.0), 100 mM KCl. Fractions containing pure recombinant protein were pooled, 
concentrated to 8-10 mg/mL using Amicon Ultra (Millipore) and stored at 4 °C. 
 
Crystallization and crystal structure determination 
Crystallization was performed at 19 °C using the sitting drop vapour diffusion method. 
Protein samples were prepared at 3 mg/mL in 50 mM Tris-HCl buffer (pH 8.0) containing 
100 mM KCl, 2 mM AdoHcy and 1 equivalent of tRNAiMet. Drops of 1 µL were prepared by 
using a Cybi-Disk robot system that mixes equal volume of protein and reservoir solutions. 
Reservoir volumes of 100 µL were used. Crystals of thTrmI were obtained in 2 M 
ammonium sulphate, isopropanol 5 % (v/v) (condition number 5 of Hampton Research 
Crystal Screen II kit). The crystals were harvested, soaked in a cryoprotectant solution (2.2 M 
ammonium sulphate, isopropanol 5 % (v/v), glycerol 20 % (v/v)) and flash-frozen in liquid 
nitrogen before data collection. Diffraction data were collected at beam line ID14-1 of the 
European Synchrotron Radiation Facility (ESRF, Grenoble, France).  
All crystallographic calculations were performed using the CCP4 suite version 651 as 
implemented in the graphical user interface.52 X-ray diffraction data were processed using 
MOSFLM53 and scaled with SCALA.54 The structure of thTrmI was solved by molecular 
replacement using the program PHASER26 and the structure of m1A58 tRNA MTase from M. 
tuberculosis (PDB entry code 1I9G) as a model. In the model, non-conserved residues were 
truncated to alanine. Model building of thTrmI was first performed with ARP/wARP55 using 
the warpNtrace automated procedure. Restrained refinements of the structure were performed 
with the program REFMAC5.56 Model and maps visualisations for manual reconstruction 
were performed with the program COOT.57 Solvent molecules were automatically added 
using ARP waters module implemented in REFMAC5. In the last stages of refinement, TLS 
parameters were refined58 using one group for each domain of the protein, i.e. the large C-
terminal domain and the small N-terminal domain. 
We computed the electrostatic surface potential using APBS Tools, an interface for 
performing APBS electrostatics calculation59 from within PyMOL (http://www.pymol.org). 
 14 
Expression and purification of tRNAiMet 
The E. coli tRNAiMet was overexpressed from plasmid pBSTtRNAfMet in E. coli JM101TR 
using a protocol derived from that of Meinnel and Blanquet.60 Briefly, after phenol extraction 
of RNAs from bacteria, total tRNA was separated by gel filtration on a HiLoad 26/60 
Superdex 75 prepgrade chromatography column (Amersham Biosciences) equilibrated in 25 
mM Tris-HCl pH 7.0. The overexpressed tRNAiMet was then separated from other tRNAs by 
an anion exchange step (Resource Q column) equilibrated in 25 mM Tris-HCl pH 7.0. tRNAs 
were eluted using a 350 mM to 550 mM NaCl gradient in the same buffer. The fractions 
containing the purified tRNAiMet were pooled together, dialysed against 50 mM Tris-HCl, 100 
mM KCl, pH 8.0, concentrated using Amicon Ultra (Millipore) and stored at -20 °C. 
 
Electrospray ionization mass spectrometry 
Noncovalent mass spectrometry experiments were performed on an electrospray time-of-
flight mass spectrometer (LCT, Waters). Samples were continuously infused into the mass 
spectrometer with a syringe pump (Harvard Apparatus) at a flow rate of 6 µl/min. Mass 
spectra were acquired in the positive ion mode on the mass range 2000-8000 m/z after 
calibration with the multiply charged ions produced by horse heart myoglobin diluted to 2 
µM in a 1:1 water/acetonitrile mixture (v/v) acidified with 1% (v/v) formic acid. 
Deconvoluted mass spectra were obtained using the Transform algorithm of MassLynx 4.0 
software. Instrumental parameters were optimized to get the best compromise between ion 
desolvatation, ion transmission and preservation of noncovalent complexes during the 
ionization and desorption processes. This optimization concerned especially the pressure in 
the interface (Pi) and the accelerating voltage (Vc) which were set to 6.1 mbar and 120 V, 
respectively.  
Purity and homogeneity of thTrmI were checked in denaturing conditions by diluting the 
protein to 5 µM in a 1:1 water/acetonitrile mixture acidified with 1% (v/v) formic acid. A 
good agreement was found between the measured molecular mass (28863.0 ± 0.3 Da) and the 
mass calculated from the amino acid sequence (28863.3 Da). For experiments performed in 
non-denaturing conditions, different ammonium bicarbonate concentrations ranging from 100 
mM to 1250 mM were tested. A concentration of 200 mM ammonium bicarbonate was 
chosen as the best compromise to provide good quality ESI mass-spectra without extensive 
thTrmI:tRNA complexes dissociation (which takes place at high ionic strengths) or protein 
aggregation (occurring at low ionic strengths). Thus, this buffer concentration was used to 
study both thTrmI oligomerization state and its tRNA-binding properties. All experiments 
were carried out at 20 µM thTrmI (tetramer concentration) whereas E. coli tRNAiMet 
concentration (molecular weight MW = 24888 Da) was increased up to 200 µM for titration 
experiments. To study the influence of AdoHcy on the thTrmI-tRNA complexation 
equilibrium, thTrmI and AdoHcy, both at 20 µM (tetramer concentration), were incubated in 
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the ammonium bicarbonate buffer in presence or in absence of tRNA (30 µM). Finally, a 
non-substrate control RNA of 59 nucleotides (MW = 19255 Da) was also used in a five-fold 
molar excess relative to the thTrmI tetramer concentration in order to investigate the 
specificity of the thTrmI-tRNA interactions. All solutions were incubated for 15 minutes at 
room temperature before analysis under non-denaturing conditions.  
 
Non-denaturing agarose gel electrophoresis 
Samples were prepared by mixing constant amount of E. coli tRNAiMet (4 µg) with 
increasing amounts of thTrmI protein (from 0 to 1 molar equivalent of thTrmI tetramer) in 
loading buffer (Tris-HCl pH 8.0 50 mM, KCl 100 mM, glycerol 18 % (v/v)). Samples were 
kept at 4 °C for 12 hours and loaded on a 2 % (w/v) agarose gel. Migration was performed 
for one hour in Tris-Acetate buffer pH 8.0 at 4 °C under an electric field of 100 V. Bands 
were visualized by UV shadowing. 
 
Site-directed Mutagenesis 
Alanine site-directed mutagenesis was carried out using the Quickchange kit and 
protocol (Stratagene). All oligonucleotides for mutagenesis were designed to have 
appropriate pairing stability (fusion temperature near 80 °C) and were between 27 to 32 nt 
long. All mutant genes were fully sequenced and contained only the desired substitutions. 
 
Expression and purification of wild-type and mutant thTrmI proteins for kinetic studies 
The wild type and mutant proteins were overexpressed and purified as for structural 
studies except that the thrombin cleavage was omitted. Protein concentrations were evaluated 
with the Bradford method. The proteins were then diluted in 50 mM Tris-HCl pH 8.0 to a 
final concentration of 0.25 mg/mL and stored at 4 °C. 
 
Fluorescence titrations of thTrmI by tRNAiMet 
Fluorescence measurements were performed at 20 °C on a JASCO spectrofluorimeter. 
Excitation and emission wavelengths were 280 nm and 343 nm respectively. The excitation 
and emission bandwidths were 5 nm and 10 nm respectively. 
Fluorescence titrations experiments were performed by adding increasing concentrations 
of nucleic acid to a fixed amount of thTrmI protein (15 nM) in 50 mM Tris-HCl, 200 mM 
KCl, 0.5 % (w/v) PEG 8000, pH 8.0. Fluorescence intensities were corrected for dilution and 
were fitted using Eq. (1) assuming two equivalent tRNA binding sites per thTrmI tetramer 
(see Mass Spectrometry Results). 
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where I0, Fluorescence intensity without tRNA; I, fluorescence intensity at a given 
concentration of tRNA; I∞, fluorescence intensity at the plateau; n, number of tRNA binding 
sites on the protein; Nt, total concentration of protein; Lt, total concentration of tRNA. 
Confidence limits on the parameters were estimated by Monte-Carlo sampling.61 
 
Steady-state kinetic assay 
[Methyl-3H]-AdoMet (555 GBq/mmol, 20.5 MBq/mL, MP Biomedicals) was mixed with 
non-radioactive AdoMet (Sigma) to achieve a specific radioactivity of about 500 cpm/pmol 
(16.7 Bq/pmol). The methylation kinetic assays were performed in 50 mM Tris-HCl pH 8.0 
at 60 °C. The tRNA and [methyl-3H]-AdoMet were thermally equilibrated in 1.25 x 
concentrated reaction buffer (96 µL) at 60 °C for 5 min, and the reaction was started by 
adding the enzyme (24 µL). Aliquots (25 µL) were removed after different incubation times 
and transferred into 800 µL of 5 % (w/v) trichloroacetic acid (TCA) at 0 °C for 30 min in 
order to quench the reaction and to precipitate the tRNA. The precipitates were collected by 
filtration through GF/C filters (Whatman). The filters were washed with cold 5 % TCA, 
dried, and the radioactivity was measured by liquid scintillation counting for 2 min, resulting 
in a counting error below 4 %. Data were corrected by substracting the background 
radioactivity determined from a control without enzyme. 
For the determination of AdoMet KM and kcat, the reaction mixtures contained MTase (wild 
type, 25 nM ; Y194A, 50 nM ; Y78A, 100 nM ; D170A, 500 nM), tRNAiMet (20 µM) and 3H-
AdoMet (wild type, 0.5-8 µM ; Y194A, 0.5-8 µM ; Y78A, 0.5-8 µM ; D170A, 5-50 µM). For 
tRNAiMet KM and kcat, the reaction mixtures contained MTase (wild type, 25 nM ; Y194A, 50 
nM ; Y78A, 100 nM ; D170A, 500 nM), tRNAiMet (wild type, 0.5-8 µM ; Y194A, 0.5-8 µM ; 
Y78A, 0.25-4 µM ; D170A, 0.5-8 µM) and 3H-AdoMet (wild type, 20 µM ; Y194A, 50 µM ; 
Y78A, 20 µM ; D170A, 50 µM). Initial rates (vi) for each substrate concentration (tRNAiMet) 
were determined from the slope of linear fits of time course data points (wild type, 9 min ; 
Y194A, 20 min ; Y78A, 40 min ; D170A, 40 min). Enzyme parameters were obtained by 
non-linear least square fitting using Eq. (2) of Michaelis-Menten kinetics (wild type and 
mutant Y194A) or Eq. (3) in cases where enzyme concentration was not negligible compared 
to substrate concentration (mutant Y78A and D170A). kcat values were calculated for two 
catalytic sites per TrmI tetramer. Confidence limits on the parameters were estimated by 
Monte-Carlo sampling using the MC-Fit program.61 
 
(2) 
! 
v
i
=
V
max
S
0
K
M
+ S
0
 (3) 
! 
v
i
=
V
max
2E
0
K
M
+ S
0
+ E
0
" (K
M
+ S
0
+ E
0
)
2
" 4S
0
E
0( )  
 
 17 
Molecular Docking 
Docking of the N9-methyladenine ring into the active site of TrmI was performed using 
HADDOCK 1.337 (http://www.nmr.chem.uu.nl/haddock/) that makes use of CNS62 as 
structure calculation software. HADDOCK allows to deal with ambiguous constraints, i.e. 
restraints can be applied between residues and not only between atoms. The protein structure 
used for the docking was the tetrameric T. thermophilus TrmI crystal structure in which the 
AdoHcy ligand was replaced with the AdoMet methyl donor. A 2 Å distance was used to 
define ambiguous restraints (AIRs) that were applied between the adenine and a set of 
neighbours composed of AdoMet cofactor and thTrmI residues identified by mutagenesis (i.e. 
Y78, D170 and Y194). One unambiguous restraint set to 2 Å was applied between the atoms 
that react in the methyl transfer reaction, i.e. the N1 position of the N9-methyladenine ring and 
the Cε atom of the AdoMet ligand. During the rigid body energy minimisation, 2000 
structures were calculated and the 1000 best solutions based on the intermolecular energy 
were used for the semi-flexible refinement. The docking converged to a single solution. The 
same protocol was also applied to the M. tuberculosis TrmI. 
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FIGURE LEGENDS 
 
Figure 1: Crystal Structure of T. thermophilus TrmI. 
(a) Overall structure of thTrmI monomer. The secondary structure elements are labelled 
following the nomenclature defined in Schluckebier et al.63 The cofactor AdoHcy is shown in 
blue sticks. (b) Organization of thTrmI as a tetramer. Each monomer is drawn with a different 
colour. The two tight dimers are respectively in red and yellow, and in pale and dark blue. 
The tetramerization interface involved strands β6 and β7. 
(c) The AdoHcy binding site. The ligand (blue) and the enzyme residues (gray) are shown as 
sticks. Water molecules are drawn as blue spheres. Polar contacts are represented with dashed 
lines. Strictly conserved residue among m1A58 tRNA MTases are labelled with bold letters. 
Characteristic motifs from MTases are highlighted. (d) Density map (2Fo-Fc at 1σ) around 
the cofactor. The AdoHcy ligand (blue) and the enzyme residues (green) are shown as sticks. 
Water molecules are represented as red spheres. 
 
Figure 2: Electrostatic surface potential of (a) T. thermophilus TrmI and (b) M. tuberculosis 
TrmI. Blue indicates positive charge and red negative one with the maximum color saturation 
corresponding to -3 kT (red) and +3 kT (blue). The figure was prepared using the APBS59 
PyMOL plugin. 
 
Figure 3: Noncovalent ESI-MS analyses of thTrmI and thTrmI-tRNA assemblies. ESI mass 
spectra obtained under non-denaturing conditions (200 mM ammonium bicarbonate buffer 
pH 8.0; Vc = 120 V; Pi = 6.1 mbar) for (a) thTrmI tetramer (20 µM) alone and in presence of 
(b) 30 µM, (c) 100 µM and (d) 200 µM of E. coli tRNAiMet. Inserts correspond to 
deconvoluted spectra showing molecular weights on the x-scale. T (MW = 115450 ± 5 Da) 
corresponds to (thTrmI)4, T+1tRNA (MW = 140347 ± 6 Da) corresponds to 
(thTrmI)4:(tRNA)1 complex and T+2tRNA (MW = 165455 ± 10 Da) corresponds to 
(thTrmI)4:(tRNA)2 complex. (*) correspond to tRNA signals.  
 
Figure 4: Non-denaturing agarose gel electrophoresis 
Constant amount of E. coli tRNAiMet (4 µg) with increasing amounts of thTrmI protein (from 
0 to 1 molar equivalent of thTrmI tetramer). Bands were visualized by UV shadowing. 
 
Figure 5: Influence of the buffer ionic strength on thTrmI-tRNA complexes stabilities. ESI 
mass spectra obtained under non-denaturing conditions (ammonium bicarbonate pH 8.0; Vc 
= 120 V; Pi = 6.1 mbar) for thTrmI tetramer (20 µM) in presence of 100 µM of E. coli 
tRNAiMet. Ammonium bicarbonate concentration was set to (a) 100 mM, (b) 200 mM, (c) 400 
mM and (d) 1250 mM. Inserts correspond to deconvoluted spectra showing molecular 
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weights on the x-scale. T corresponds to (thTrmI)4, T+1tRNA corresponds to 
(thTrmI)4 :(tRNA)1 complex and T+2tRNA corresponds to (thTrmI)4:(tRNA)2 complex. (*) 
correspond to tRNA signals. 
 
Figure 6: Specificity of thTrmI-tRNA complexes formation. ESI mass spectra obtained under 
non-denaturing conditions (200 mM ammonium bicarbonate buffer pH 8.0; Vc = 120 V; Pi = 
6.1 mbar) for thTrmI tetramer (20 µM) in presence of (a) 100 µM E. coli tRNAiMet (b) 100 
µM non substrate control RNA. Inserts correspond to deconvoluted spectra showing 
molecular weights on the x-scale. T corresponds to (thTrmI)4, T+1tRNA corresponds to 
(thTrmI)4 :(tRNA)1 complex and T+2tRNA corresponds to (thTrmI)4:(tRNA)2 complex. (*) 
corresponds to RNA signal. 
 
Figure 7: Sequence alignments of TrmI proteins and conserved residues in thTrmI catalytic 
pocket. 
(a) Part of sequence alignment of T. thermophilus, M. tuberculosis, P. abyssi, M. musculus, 
H. sapiens and S. cerevisiae m1A58 tRNA MTases. Residue numbers are those of T. 
thermophilus sequence. Highly conserved residues are shown on a dark blue background and 
residues with a similar physico-chemical character are on a pale blue background. The 
secondary structure of the T. thermophilus TrmI is shown below the sequences as arrows for 
β-strands and cylinder for α-helices. The names of the secondary structure elements refer to 
Figure 1(a). The sequence motifs typical of the AdoMet dependent MTase family are also 
indicated. Residues marked with a star (*) (i.e. Y78, D170 and Y194) are involved in the 
catalytic pocket formation and are those studied by mutagenesis in the present work. 
Residues marked with a circle (o) (i.e. W175 and F245) are conserved aromatic residues in 
motifs IV and VIII, belonging to the catalytic pocket in m6A DNA MTases. (b) Conserved 
and semi-conserved residues around the catalytic pocket of T. thermophilus TrmI. The strictly 
conserved residues among the m1A58 tRNA MTase family are shown as sticks on the T. 
thermophilus structure except the conserved residues that bind AdoMet. AdoMet was 
modeled from AdoHcy by adding a methyl group on the sulphur atom, the methyl is 
positionned by the sulfonium chirality. Y78, Y194 and D170 are indicated as red sticks.  
 
Figure 8: Modeling a N9-methyladenine in the catalytic pocket of thTrmI 
(a) Average docked structure of the N9-methyladenine ring inside the catalytic pocket of 
thTrmI. The enzyme surface is coloured according to the electrostatic surface potential. 
Positive potential is shown in blue and negative potential in red. The AdoMet ligand and the 
docked N9-methyladenine ring are shown as sticks (carbon atoms in light blue, nitrogen 
atoms in dark blue, oxygen atoms in red, sulphur atom in yellow and hydrogen atoms in 
white). The Van der Waals surface of the N9-methyladenine ring is shown as white dots. 
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(b) Distances between the average structure of the docked N9-methyladenine ring and key 
moiety of the enzyme. The enzyme is shown in gray with the cartoon representation. The 
AdoMet ligand, the docked N9-methyladenine ring and residues D170, Y78 and Y194 are 
shown as sticks. Distances are indicated with dashed lines and are given in Å. 








Table 1 Data collection and refinement statistics for the determination of TrmI structure. 
Values in parenthesis are for the outer resolution shell. 
 
A. Data collection statistics     B. Refinement statistics   
Wavelength (Å) 0.9340  Resolution limits (Å) 33.67-1.70 (1.74-1.70) 
Space group C2221  Number of reflections 64480 (4709) 
Unit-cell parameters (Å)   R-factor (%) 18.0 (24.7) 
a 90.4406  Rfree (%) 20.9 (27.9) 
b 96.7946  Number of atoms 4311 
c 140.5837  Protein 3823 
No. of measured reflections 499190 (71441)  Ligands 67 
No. of unique reflections 67981 (9830)  Waters 421 
Multiplicity 7.3 (7.3)  Mean B-factors (Å2) 15.92 
Resolution limits (Å) 48.39-1.70 (1.79-1.70)  RMSD (bounds) (Å) 0.009 
Data completeness (%) 100.0 (100.0)  RMSD (angles) (°) 1.265 
Mean I/σ(I) 13.6 (2.9)    
Rmerge 10.6 (67.6)    
         
 
 
Table 2 Kinetic and thermodynamic parameters of wild-type and mutant TrmI enzymes. 
The parameters are indicated with a confidence interval of 90 %. 
 
  AdoMet       tRNAiMet    
Mutants kcat (s-1 x 10-3) KM (µM)  kcat (s-1 x 10-3) KM  (µM) KD (nM) Relative kcat 
WT 37 (30 - 44) 2.1 (1.4-3.0)   36 (28 - 45) 2.7 (1.7-4.8) 13 (5 - 24) 100.0 
Y194A 6 (5 – 11) 5.7 (3.9-8.7)   10 (9 - 13) 2.2 (1.9-3.3) 18 (10 - 37) 27.4 
Y78A 1.4 (1.1 – 1.7) 1.9 (1.2-2.7)   1.6 (1.5 – 1.8) 0.16 (0.11-0.23) 16 (7 - 33) 4.1 
D170A 0.13 (0.11 - 0.14) 5.4 (3.7-8.0)   0.11 (0.10 - 0.12) 0.17 (0.07-0.39) 14 (6 - 25) 0.3 
 
 
 
 
Figure 1 (Supplementary Material): Determination of the catalytic parameters of wild type 
thTrmI enzyme. 
(a) Time course measurements of incorporated 3H-Methyl in tRNAiMet for different AdoMet 
concentrations (0.5, 1, 2, 4, 8 µM). (b) Michaelis-Menten fit of initial rates corresponding to 
several AdoMet concentrations. 
 
 
